Received: 7 December 2017
Accepted: 9 April 2018
First Online: 19 May 2018
Ethics approval and consent to participate
: Ethical approval was granted by Ministry of Health Malaysia Medical Research Ethics Committee.
: Written consent was obtained from the patient’s next-of-kin for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.
: T.E. Warkentin reports consulting fees from Aspen Global, research support and consulting fees from W.L. Gore, research support and consulting fees from Instrumentation Laboratory, research support and consulting fees from Medtronic Diabetes, consulting fees from Octapharma, royalties from Informa (Taylor & Francis), and consulting fees relating to medical-legal testimony. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.